Radiation Oncology | Articles preview

2022-05-18 12:54:37 Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk HPV-Negative Head and Neck Cancer from a Phase II Clinical Trial: NRG Oncology RTOG 0234
https://www.advancesradonc.org/article/S2452-1094(22)00096-3/fulltext?rss=yes

An evolutionary action scoring algorithm (EAp53) based on phylogenetic sequence variations stratifies head and neck squamous cell carcinoma (HNSCC) patients bearing TP53 missense mutations as high-risk, associated with poor outcomes, or low-risk, with similar outcomes as TP53 wild-type, and has been validated as a reliable prognostic marker. We performed this study to further validate prior findings demonstrating that EAp53 is a prognostic marker for locally advanced HNSCC patients, and explore its predictive value for treatment outcomes to adjuvant bio-chemoradiotherapy. Open / Comment

2022-05-18 03:48:03 Percutaneous Radiofrequency Ablation to Occlude the Thoracic Duct: Preclinical Studies in Swine for a Potential Alternative to Embolization
https://www.jvir.org/article/S1051-0443(22)00935-6/fulltext?rss=yes

To investigate the feasibility of percutaneous radiofrequency ablation (RFA) to occlude the thoracic duct (TD) in a swine model with imaging and histologic correlation. Open / Comment

2022-05-17 21:10:04 Retraction Note to: IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-022-02030-5 Open / Comment

2022-05-14 01:15:36 Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-022-02064-9

This study aimed to explore the pattern of locoregional recurrence after surgery in patients with non-metastatic stage pT4 sigmoid colon cancer and the role of adjuvant radiotherapy on survival. Open / Comment

2022-05-12 17:23:28 Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-022-02061-y

Prostate cancer is the second most common malignancy worldwide, and the majority of patients are diagnosed with localized disease. We examined patients’ quality of life after stereotactic body radiation therap... Open / Comment

2022-05-12 17:22:37 The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-022-02063-w

To analyze the prognostic factors associated with stage IB-IVA cervical cancer in patients who underwent concurrent chemoradiation therapy (CCRT) and to compare the clinical toxicities and dosimetric parameter... Open / Comment

2022-05-12 17:21:32 Protective ileostomy increased the incidence of rectal stenosis after anterior resection for rectal cancer
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-022-02031-4

In most of the views, rectal stenosis after anterior resection for rectal cancer results from pelvic radiotherapy. However, patients without receiving radiotherapy also suffer stenosis. In this study, we evalu... Open / Comment

2022-05-12 17:21:08 30-day mortality in patients treated for brain metastases: extracranial causes dominate
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-022-02062-x

Established prognostic models, such as the diagnosis-specific graded prognostic assessment, were not designed to specifically address very short survival. Therefore, a brain metastases-specific 30-day mortalit... Open / Comment

2022-05-12 17:19:28 Feasibility of postoperative spine stereotactic body radiation therapy in proximity of carbon and titanium hybrid implants using a robotic radiotherapy device
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-022-02058-7

To assess the feasibility of postoperative stereotactic body radiation therapy (SBRT) for patients with hybrid implants consisting of carbon fiber reinforced polyetheretherketone and titanium (CFP-T) using Cyb... Open / Comment

2022-05-12 12:40:38 Feasibility of drug-eluting embolics chemoembolization for the management of recurrent/advanced head and neck cancer
https://www.jvir.org/article/S1051-0443(22)00901-0/fulltext?rss=yes

To characterize the safety, tolerability, and efficacy of chemoembolization with drug-eluting embolic (DEE) microspheres in patients with recurrent and advanced head and neck cancer. Open / Comment